Tissue-specific transcription profile of cytokine and chemokine genes associated with flavivirus control and non-lethal neuropathogenesis in rabbits

Virology

Volumn 494, Issue , 2016, Pages 1-14

  Suen, Willy W ^a   Uddin, Muhammad Jasim ^a   Prow, Natalie A ^a,c   Bowen, Richard A ^b   Hall, Roy A ^a   Bielefeldt Ohmann, Helle ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Veterinary Dentistry and Oral Surgery   (United States)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Chemokine; Cytokine; Flavivirus; Murray Valley encephalitis virus; Neuropathogenesis; Rabbit; Virus control; West Nile virus

Indexed keywords

ALPHA INTERFERON; CHEMOKINE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6; STAT1 PROTEIN; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOKINE GENE; CONTROLLED STUDY; CXCL10 GENE; CYTOKINE GENE; FLAVIVIRUS; GENE; GENETIC ASSOCIATION; IFNALPHA GENE; IFNGAMMA GENE; IL6 GENE; INTRACELLULAR SIGNALING; MURRAY VALLEY ENCEPHALITIS; MURRAY VALLEY ENCEPHALITIS VIRUS; NEUROPATHOLOGY; NEW ZEALAND WHITE (RABBIT); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYLVILAGUS; TISSUE SPECIFICITY; TNFALPHA GENE; TRANSCRIPTION REGULATION; UPREGULATION; VIRUS VIRULENCE; WEST NILE FEVER; WEST NILE VIRUS; AGE; ANIMAL; ANIMAL DISEASE; ANTIBODY SPECIFICITY; BIOLOGICAL MODEL; FEMALE; FLAVIVIRUS INFECTION; GENE EXPRESSION PROFILING; GENETICS; HOST PATHOGEN INTERACTION; MALE; MORTALITY; NEUROLOGIC DISEASE; PHYSIOLOGY; RABBITS AND HARES; SEX DIFFERENCE; SPECIES DIFFERENCE; TIME FACTOR; VETERINARY; VIROLOGY;

AGE FACTORS; ANIMAL DISEASES; ANIMALS; CHEMOKINES; CYTOKINES; FEMALE; FLAVIVIRUS; FLAVIVIRUS INFECTIONS; GENE EXPRESSION PROFILING; HOST-PATHOGEN INTERACTIONS; INFLAMMATION MEDIATORS; MALE; MODELS, BIOLOGICAL; NERVOUS SYSTEM DISEASES; NF-KAPPA B; ORGAN SPECIFICITY; RABBITS; SEX FACTORS; SPECIES SPECIFICITY; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; TIME FACTORS; TRANSCRIPTOME;

EID: 84962734312     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2016.03.026     Document Type: Article

References (53)

1. Audsley M., Edmonds J., Liu W., Mokhonov V., Mokhonova E., Melian E.B., et al. Virulence determinants between New York 99 and Kunjin strains of West Nile virus. Virology 2011, 414:63-73.
2. Best S.M., Kerr P.J. Coevolution of host and virus: the pathogenesis of virulent and attenuated strains of myxoma virus in resistant and susceptible European rabbits. Virology 2000, 267:36-48.
3. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., Salazar-Mather T.P. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 1999, 17:189-220.
4. Biswas S.K., Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 2010, 11:889-896.
5. Bourgeois M.A., Denslow N.D., Seino K.S., Barber D.S., Long M.T. Gene expression analysis in the thalamus and cerebrum of horses experimentally infected with West Nile virus. Plos One 2011, 6:e24371.
6. Carmo C.R., Esteves P.J., Ferrand N., van der Loo W. Genetic variation at chemokine receptor CCR5 in leporids: alteration at the 2nd extracellular domain by gene conversion with CCR2 in Oryctolagus, but not in Sylvilagus and Lepus species. Immunogenetics 2006, 58:494-501.
7. Cheeran M.C., Hu S., Sheng W.S., Rashid A., Peterson P.K., Lokensgard J.R. Differential responses of human brain cells to West Nile virus infection. J. Neurovirol. 2005, 11:512-524.
8. Christmas S.E., Meager A. Production of interferon-gamma and tumor-necrosis-factor-alpha by human t-cell clones expressing different forms of the gamma-delta-receptor. Immunology 1990, 71:486-492.
9. Cray C., Zaias J., Altman N.H. Acute phase response in animals: a review. Comp. Med. 2009, 59:517-526.
10. Dalgarno L., Trent D.W., Strauss J.H., Rice C.M. Partial nucleotide sequence of the Murray Valley encephalitis virus genome. Comparison of the encoded polypeptides with yellow fever virus structural and non-structural proteins. J. Mol. Biol. 1986, 187:309-323.
11. de Matos A.L., van der Loo W., Areal H., Lanning D.K., Esteves P.J. Study of Sylvilagus rabbit TRIM5alpha species-specific domain: how ancient endoviruses could have shaped the antiviral repertoire in Lagomorpha. BMC Evol. Biol. 2011, 11:294.
12. Fernando M.R., Reyes J.L., Iannuzzi J., Leung G., McKay D.M. The pro-inflammatory cytokine, interleukin-6, enhances the polarization of alternatively activated macrophages. Plos One 2014, 9:e94188.
13. Frost M.J., Zhang J., Edmonds J.H., Prow N.A., Gu X., Davis R., et al. Characterization of virulent West Nile virus Kunjin strain, Australia, 2011. Emerg. Infect. Dis. 2012, 18:792-800.
14. Girdlestone J., Wing M. Autocrine activation by interferon-gamma of STAT factors following T cell activation. Eur. J. Immunol. 1996, 26:704-709.
15. Hutchins A.P., Diez D., Miranda-Saavedra D. The IL-10/STAT3-mediated anti-inflammatory response: recent developments and future challenges. Brief. Funct. Genom. 2013, 12:489-498.
16. Ivashkiv L.B., Donlin L.T. Regulation of type I interferon responses. Nat. Rev. Immunol. 2014, 14:36-49.
17. Kerr P.J., Best S.M. Myxoma virus in rabbits. Rev. Sci. Technol. 1998, 17:256-268.
18. Kerr P.J., Donnelly T.M. Viral infections of rabbits. Vet. Clin. N. Am. Exot. Anim. Pract. 2013, 16:437-468.
19. Levy D.E., Lee C.-k What does Stat3 do?. J. Clin. Invest. 2002, 109:1143-1148.
20. Lindsey N.P., Staples J.E., Lehman J.A., Fischer M. Surveillance for human West Nile virus disease - United States, 1999-2008. MMWR Surveill. Summ. 2010, 59:1-17.
21. Lobigs M., Marshall I.D., Weir R.C., Dalgarno L. Genetic differentiation of Murray Valley encephalitis virus in Australia and Papua New Guinea. Aust. J. Exp. Biol. Med. Sci. 1986, 64(6):571-585.
22. Mehlhop E., Diamond M.S. The molecular basis of antibody protection against West Nile virus. Curr. Top. Microbiol. Immunol. 2008, 317:125-153.
23. Mostashari F., Bunning M.L., Kitsutani P.T., Singer D.A., Nash D., Cooper M.J., et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 2001, 358:261-264.
24. Nagyoszi P., Wilhelm I., Farkas A.E., Fazakas C., Dung N.T., Hasko J., et al. Expression and regulation of toll-like receptors in cerebral endothelial cells. Neurochem. Int. 2010, 57:556-564.
25. Neves F., Abrantes J., Pinheiro A., Almeida T., Costa P.P., Esteves P.J. Convergent evolution of IL-6 in two leporids (Oryctolagus and Pentalagus) originated an extended protein. Immunogenetics 2014, 66:589-595.
26. Ng S.L., Friedman B.A., Schmid S., Gertz J., Myers R.M., Tenoever B.R., et al. IkappaB kinase epsilon (IKK(epsilon)) regulates the balance between type I and type II interferon responses. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:21170-21175.
27. Nielsen C.F., Reisen W.K., Armijos M.V., Maclachlan N.J., Scott T.W. High subclinical West Nile virus incidence among nonvaccinated horses in northern California associated with low vector abundance and infection. Am. J. Trop. Med. Hyg. 2008, 78:45-52.
28. Opal S.M., DePalo V.A. Anti-inflammatory cytokines. Chest 2000, 117:1162-1172.
29. Parameswaran N., Patial S. Tumor Necrosis Factor-α Signaling in Macrophages. Crit. Rev. Eukaryot. Gene Exp. 2010, 20:87-103.
30. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
31. Pozzi L.-A.M., Maciaszek J.W., Rock K.L. Both dendritic cells and macrophages can stimulate naive CD8 T cells in vivo to proliferate, develop effector function, and differentiate into memory cells. J. Immunol. 2005, 175:2071-2081.
32. Pusterla N., Wilson W.D., Conrad P.A., Mapes S., Leutenegger C.M. Comparative analysis of cytokine gene expression in cerebrospinal fluid of horses without neurologic signs or with selected neurologic disorders. Am. J. Vet. Res. 2006, 67:1433-1437.
33. Romano M., Sironi M., Toniatti C., Polentarutti N., Fruscella P., Ghezzi P., et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997, 6:315-325.
34. Sabouri A.H., Marcondes M.C., Flynn C., Berger M., Xiao N., Fox H.S., et al. TLR signaling controls lethal encephalitis in WNV-infected brain. Brain Res. 2014, 1574:84-95.
35. Scheller J., Chalaris A., Schmidt-Arras D., Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim. Biophys. Acta 2011, 1813:878-888.
36. Schnupf P., Sansonetti P.J. Quantitative RT-PCR profiling of the rabbit immune response: assessment of acute Shigella flexneri infection. Plos One 2012, 7:e36446.
37. Shirato K., Kimura T., Mizutani T., Kariwa H., Takashima I. Different chemokine expression in lethal and non-lethal murine West Nile virus infection. J. Med. Virol. 2004, 74:507-513.
38. Shrestha B., Wang T., Samuel M.A., Whitby K., Craft J., Fikrig E., et al. Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection. J. Virol. 2006, 80:5338-5348.
39. Shrestha B., Zhang B., Purtha W.E., Klein R.S., Diamond M.S. Tumor necrosis factor alpha protects against lethal West Nile Virus infection by promoting trafficking of mononuclear leukocytes into the central nervous system. J. Virol. 2008, 82:8956-8964.
40. Suen W.W., Prow N.A., Hall R.A., Bielefeldt-Ohmann H. Mechanism of West Nile virus neuroinvasion: a critical appraisal. Viruses. 2014, 6:2796-2825.
41. Suen W.W., Uddin M.J., Wang W., Brown V., Adney D.R., Broad N., et al. Experimental West Nile virus infection in rabbits: an alternative model for studying induction of disease and virus control. Pathogens 2015, 4:529-558.
42. Suthar M.S., Diamond M.S., Gale M. West Nile virus infection and immunity. Nat. Rev. Microbiol. 2013, 11:115-128.
43. Tolnay A.E., Baskin C.R., Tumpey T.M., Sabourin P.J., Sabourin C.L., Long J.P., et al. Extrapulmonary tissue responses in cynomolgus macaques (Macaca fascicularis) infected with highly pathogenic avian influenza A (H5N1) virus. Arch. Virol. 2010, 155:905-914.
44. Town T., Bai F., Wang T., Kaplan A.T., Qian F., Montgomery R.R., et al. Toll-like receptor 7 mitigates lethal West Nile encephalitis via interleukin 23-dependent immune cell infiltration and homing. Immunity 2009, 30:242-253.
45. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 1995, 13:251-276.
46. Trobaugh D., Green S. Of mice and men: protective and pathogenic immune responses to west nile virus infection. Curr. Trop. Med. Rep. 2015, 2:41-48.
47. Uddin M.J., Suen W.W., Prow N.A., Hall R.A., Bielefeldt-Ohmann H. West Nile virus challenge alters the transcription profiles of innate immune genes in rabbit peripheral blood mononuclear cells. Front. Vet. Sci. 2015, 2:76.
48. van der Loo W., Afonso S., de Matos A.L., Abrantes J., Esteves P.J. Pseudogenization of the MCP-2/CCL8 chemokine gene in European rabbit (genus Oryctolagus), but not in species of Cottontail rabbit (Sylvilagus) and Hare (Lepus). BMC Genet. 2012, 13:72.
49. Venter M., Swanepoel R. West Nile virus lineage 2 as a cause of zoonotic neurological disease in humans and horses in southern Africa. Vector Borne Zoonotic Dis. 2010, 10:659-664.
50. Venter M., Myers T.G., Wilson M.A., Kindt T.J., Paweska J.T., Burt F.J., et al. Gene expression in mice infected with West Nile virus strains of different neurovirulence. Virology 2005, 342:119-140.
51. Venter M., Burt F.J., Blumberg L., Fickl H., Paweska J., Swanepoel R. Cytokine induction after laboratory-acquired West Nile virus infection. N. Engl. J. Med. 2009, 360:1260-1262.
52. Wang T., Town T., Alexopoulou L., Anderson J.F., Fikrig E., Flavell R.A. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 2004, 10:1366-1373.
53. Zakharova M., Ziegler H.K. Paradoxical anti-inflammatory actions of TNF-alpha: inhibition of IL-12 and IL-23 via TNF receptor 1 in macrophages and dendritic cells. J. Immunol. 2005, 175:5024-5033.